225 related articles for article (PubMed ID: 31994248)
1. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy.
Zhang X; Thomas C; Schiano TD; Thung SN; Ward SC; Fiel MI
Histopathology; 2020 Jun; 76(7):959-967. PubMed ID: 31994248
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH).
Büyük M; Berker N; Bakkaloğlu DV; Şenkal İV; Önal Z; Güllüoğlu M
Hepatol Int; 2024 Jun; 18(3):1011-1019. PubMed ID: 38536628
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
Barge S; Grando V; Nault JC; Broudin C; Beaugrand M; Ganne-Carrié N; Roulot D; Ziol M
Liver Int; 2016 Jul; 36(7):1059-66. PubMed ID: 26415006
[TBL] [Abstract][Full Text] [Related]
4. Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: A case report and review of the published work.
Agrawal M; Rahmani R; Nakkala K; Fiel MI; Schiano T
Hepatol Res; 2013 Sep; 43(9):999-1003. PubMed ID: 23675894
[TBL] [Abstract][Full Text] [Related]
5. Nodular regenerative hyperplasia - An under-recognized vascular disorder of liver.
Bakshi N; Gulati N; Rastogi A; Chougule A; Bihari C; Jindal A
Pathol Res Pract; 2020 Apr; 216(4):152833. PubMed ID: 32164988
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
7. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining.
Navale P; Gonzalez RS
Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice.
Dill MT; Rothweiler S; Djonov V; Hlushchuk R; Tornillo L; Terracciano L; Meili-Butz S; Radtke F; Heim MH; Semela D
Gastroenterology; 2012 Apr; 142(4):967-977.e2. PubMed ID: 22245843
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the endothelial genes Notch1 and ephrinB2 in patients with nodular regenerative hyperplasia.
Rothweiler S; Terracciano L; Tornillo L; Dill MT; Heim MH; Semela D
Liver Int; 2014 Apr; 34(4):594-603. PubMed ID: 23870033
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of 15 cases of liver nodular regenerative hyperplasia.
Guo T; Qian J; Zhu L; Zhou W; Zhu F; Sun G; Fang X
Cell Biochem Biophys; 2012 Nov; 64(2):115-21. PubMed ID: 22707296
[TBL] [Abstract][Full Text] [Related]
11. Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis.
Ozturk NB; Fiel MI; Schiano TD
JGH Open; 2022 Sep; 6(9):607-611. PubMed ID: 36091322
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.
Goel A; Elias JE; Eapen CE; Ramakrishna B; Elias E
J Clin Exp Hepatol; 2014 Sep; 4(3):247-56. PubMed ID: 25755567
[TBL] [Abstract][Full Text] [Related]
13. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension.
Kondo F; Nagao T; Sato T; Tomizawa M; Kondo Y; Matsuzaki O; Wada K; Wakatsuki S; Nagao K; Tsubouchi H; Kobayashi H; Yasumi K; Tsukayama C; Suzuki M
Pathol Res Pract; 1998; 194(7):487-95. PubMed ID: 9728365
[TBL] [Abstract][Full Text] [Related]
14. Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver.
Ziol M; Poirel H; Kountchou GN; Boyer O; Mohand D; Mouthon L; Tepper M; Guillet JG; Guettier C; Raphael M; Beaugrand M
Hum Pathol; 2004 Oct; 35(10):1241-51. PubMed ID: 15492992
[TBL] [Abstract][Full Text] [Related]
15. Nodular regenerative hyperplasia associated to aplastic anemia: a case report and literature review.
González-Huezo MS; Villela LM; Zepeda-Florencio Mdel C; Carrillo-Ponce CS; Mondragón-Sánchez RJ
Ann Hepatol; 2006; 5(3):166-9. PubMed ID: 17060874
[TBL] [Abstract][Full Text] [Related]
16. Obliterative portal venopathy without portal hypertension: an underestimated condition.
Guido M; Sarcognato S; Sonzogni A; Lucà MG; Senzolo M; Fagiuoli S; Ferrarese A; Pizzi M; Giacomelli L; Colloredo G
Liver Int; 2016 Mar; 36(3):454-60. PubMed ID: 26264219
[TBL] [Abstract][Full Text] [Related]
17. Dissociation in hepatic vein pressure gradient, liver stiffness measurement and complications in histological subtypes of porto-sinusoidal vascular disease.
Bihari C; Dhariwal S; Shasthry SM; Rastogi A; Sharma MK; Sarin SK
J Clin Pathol; 2024 Feb; ():. PubMed ID: 38242555
[TBL] [Abstract][Full Text] [Related]
18. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria.
Liang J; Shi C; Dupont WD; Salaria SN; Huh WJ; Correa H; Roland JT; Perri RE; Washington MK
Mod Pathol; 2021 Mar; 34(3):592-602. PubMed ID: 32958831
[TBL] [Abstract][Full Text] [Related]
19. Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease.
Biecker E; Trebicka J; Fischer HP; Sauerbruch T; Lammert F
Z Gastroenterol; 2006 May; 44(5):395-8. PubMed ID: 16688657
[TBL] [Abstract][Full Text] [Related]
20. Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.
Hartleb M; Gutkowski K; Milkiewicz P
World J Gastroenterol; 2011 Mar; 17(11):1400-9. PubMed ID: 21472097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
